Shares of Veracyte Inc (Symbol: VCYT) recently crossed the average analyst 12-month target price of $29.40, trading at $29.94 per share. This target is based on five different analyst evaluations, which range from a low of $22.00 to a high of $35.00, with a standard deviation of $5.128.
Currently, the analyst consensus includes three Strong Buy ratings, two Buy ratings, one Hold rating, and one Strong Sell rating, resulting in an average rating of 2.04 on a scale where 1 is Strong Buy and 5 is Strong Sell. This indicates a bullish outlook on the stock, urging investors to reassess their positions in light of the recent price movements.
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
